The ethics of phase I trials of biologic agents

被引：2
|
作者：
Hanauer, Stephen B.
机构：
[1] SB Hanauer is Editor-in-Chief of Nature Clinical Practice Gastroenterology & Hepatology.,
来源：
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY | 2008年 / 5卷 / 10期
关键词：
D O I：
10.1038/ncpgasthep1259
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：533 / 533
页数：1
相关论文
共 50 条
  • [1] The ethics of phase I trials of biologic agents
    Stephen B Hanauer
    Nature Clinical Practice Gastroenterology & Hepatology, 2008, 5 : 533 - 533
  • [2] A PHASE-I TRIAL ON THE ETHICS OF PHASE-I TRIALS
    EMANUEL, EJ
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (05) : 1049 - 1051
  • [3] ETHICS OF PHASE-I CLINICAL-TRIALS
    CAPRON, AM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 249 (07): : 882 - 883
  • [4] Phase I trials of antitumour agents: fundamental concepts
    Toloi, Diego de Araujo
    Fontes Jardim, Denis Leonardo
    Gehm Hoff, Paulo Marcelo
    Pimenta Riechelmann, Rachel Simoes
    ECANCERMEDICALSCIENCE, 2015, 9
  • [5] ARE THERE SPECIAL CONSIDERATIONS RELEVANT TO TRIALS OF BIOLOGIC AGENTS
    STRAND, V
    JOURNAL OF RHEUMATOLOGY, 1994, 21 : 41 - 45
  • [6] Multi-institutional phase I trials of anticancer agents
    Dowlati, Afshin
    Manda, Sudhir
    Gibbons, Joseph
    Remick, Scot C.
    Patrick, Lauren
    Fu, Pingfu
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (12) : 1926 - 1931
  • [7] THERAPEUTIC RESPONSE IN PHASE-I TRIALS OF ANTINEOPLASTIC AGENTS
    ESTEY, E
    HOTH, D
    SIMON, R
    MARSONI, S
    LEYLANDJONES, B
    WITTES, R
    CANCER TREATMENT REPORTS, 1986, 70 (09): : 1105 - 1115
  • [8] Lower toxicity with targeted anticancer agents in phase I trials
    Reactions Weekly, 2012, 1416 (1) : 3 - 3
  • [9] Dynamic and modern: Bringing the ethics of phase I trials up to date
    Camidge, D. Ross
    Eckhardt, S. Gail
    Gore, Lia
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (32) : 5178 - 5179
  • [10] ARE THERE SPECIAL CONSIDERATIONS RELEVANT TO TRIALS OF BIOLOGIC AGENTS - COMMENT
    MAINI, RN
    JOURNAL OF RHEUMATOLOGY, 1994, 21 : 47 - 48
12345